NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Sponsor: Emory University
Conditions: Sexually Transmitted Infections, Gay, Pre Exposure Prophylaxis
Interventions: Quantitative survey, HIV and STI testing, Qualitative Assessment
Countries: United States
The goal of this observational study is to learn about awareness around PrEP use and adherence, condom use, sexual risk-taking behavior, and substance-using behaviors in men having sex with men. The main objective is to study a prospective cohort of MSM in Atlanta, Chicago, and San Diego to understand men's strategies to prevent HIV/Sexually Transmissible Infections (STIs), including PrEP use and adherence, condom use, sexual risk-taking behavior, and substance-using behaviors Participants will complete: * Quantitative surveys quarterly * HIV/ STI testing every 6 months * Qualitative assessments: focus group discussions and in-depth interviews
Sex: MALE
Age: 18 Years to —
Healthy volunteers: Yes
Study type: OBSERVATIONAL
Inclusion Criteria: * Male at birth * Self-identify as Cis-gender Male * Ages 18 or older * ≥1 Male anal sex partner in the 6 months before the baseline screener * Live in or near Atlanta, Chicago, or San Diego * Owns cell phone with data service * Willing to download a health-related app to their cell phone as part of the research study * Willing to participate in a 2-year cohort study with quarterly surveys and HIV and mailed STI self-testing * Able to provide ≥ 2 means of contact * Not currently enrolled in another HIV prevention clinical trial * Not currently living with HIV Exclusion Criteria: * Female at birth * Do not self-identify as Cis-gender Male * Individuals \< 18 years of age * HIV positive status * No male anal sex partner in the 6 months before the baseline interview * Does not own a mobile phone with data service * Not willing to download a health-related app to their cell phone as part of the research study * Live outside the metro Atlanta Metropolitan Statistical Area and/or planning to move from the Atlanta area in the next 2 years * Currently enrolled in an HIV prevention or treatment clinical trial
- San Diego, California, United States
- Atlanta, Georgia, United States
- Chicago, Illinois, United States